Vimarsana
Biggest News Aggregation in the World

Page 22 - Entrypoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entrypoint Capital Today - Breaking & Trending Today

Republic Services (NYSE:RSG) Coverage Initiated at Deutsche Bank Aktiengesellschaft - Vimarsana News

Republic Services (NYSE:RSG) Coverage Initiated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft started coverage on shares of Republic Services (NYSE:RSG – Free Report) in a research note published on Thursday, MarketBeat.com reports. The brokerage issued a hold rating and a $203.00 price objective on the business services provider’s stock. A number of other research analysts have also commented on RSG. The Goldman Sachs Group […]

Deckers Outdoor (NYSE:DECK) Price Target Raised to $1,039.00 at TD Cowen - Vimarsana News

Deckers Outdoor (NYSE:DECK) Price Target Raised to $1,039.00 at TD Cowen

Deckers Outdoor (NYSE:DECK – Free Report) had its target price boosted by TD Cowen from $1,005.00 to $1,039.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the textile maker’s stock. Other equities research analysts also recently issued reports about the company. Evercore ISI […]

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts - Vimarsana News

Cytokinetics, Incorporated (NASDAQ:CYTK) Receives Consensus Rating of "Moderate Buy" from Analysts

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12 month price objective among […]

Cabaletta Bio (NASDAQ:CABA) Earns "Buy" Rating from HC Wainwright - Vimarsana News

Cabaletta Bio (NASDAQ:CABA) Earns "Buy" Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Other equities research analysts have also issued reports about the stock. Wells Fargo & Company increased their target price on […]

Lindsay Co. (NYSE:LNN) Given Consensus Rating of "Moderate Buy" by Brokerages - Vimarsana News

Lindsay Co. (NYSE:LNN) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Lindsay Co. (NYSE:LNN – Get Free Report) have received an average rating of “Moderate Buy” from the four ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month target […]

Source: wkrb13.com